Exact Sciences (EXAS) Revenue (2016 - 2025)
Historic Revenue for Exact Sciences (EXAS) over the last 17 years, with Q3 2025 value amounting to $850.7 million.
- Exact Sciences' Revenue rose 2004.98% to $850.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 billion, marking a year-over-year increase of 1447.46%. This contributed to the annual value of $2.8 billion for FY2024, which is 1036.5% up from last year.
- According to the latest figures from Q3 2025, Exact Sciences' Revenue is $850.7 million, which was up 2004.98% from $811.1 million recorded in Q2 2025.
- Exact Sciences' 5-year Revenue high stood at $850.7 million for Q3 2025, and its period low was $402.1 million during Q1 2021.
- Over the past 5 years, Exact Sciences' median Revenue value was $622.1 million (recorded in 2023), while the average stood at $604.1 million.
- The largest annual percentage gain for Exact Sciences' Revenue in the last 5 years was 6172.21% (2021), contrasted with its biggest fall of 160.25% (2021).
- Over the past 5 years, Exact Sciences' Revenue (Quarter) stood at $473.8 million in 2021, then increased by 16.71% to $553.0 million in 2022, then rose by 16.98% to $646.9 million in 2023, then rose by 10.29% to $713.4 million in 2024, then grew by 19.25% to $850.7 million in 2025.
- Its Revenue stands at $850.7 million for Q3 2025, versus $811.1 million for Q2 2025 and $706.8 million for Q1 2025.